Literature DB >> 33843388

How can a traffic light properly work if it is always green? The paradox of CK2 signaling.

Christian Borgo1, Claudio D'Amore1, Luca Cesaro1, Stefania Sarno1, Lorenzo A Pinna1,2, Maria Ruzzene1,2, Mauro Salvi1.   

Abstract

CK2 is a constitutively active protein kinase that assuring a constant level of phosphorylation to its numerous substrates supports many of the most important biological functions. Nevertheless, its activity has to be controlled and adjusted in order to cope with the varying needs of a cell, and several examples of a fine-tune regulation of its activity have been described. More importantly, aberrant regulation of this enzyme may have pathological consequences, e.g. in cancer, chronic inflammation, neurodegeneration, and viral infection. Our review aims at summarizing our current knowledge about CK2 regulation. In the first part, we have considered the most important stimuli shown to affect protein kinase CK2 activity/expression. In the second part, we focus on the molecular mechanisms by which CK2 can be regulated, discussing controversial aspects and future perspectives.

Entities:  

Keywords:  Protein phosphorylation; biological stimuli; kinase activity; signal transduction

Year:  2021        PMID: 33843388     DOI: 10.1080/10409238.2021.1908951

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  8 in total

1.  Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate.

Authors:  Simone Fabbian; Gabriele Giachin; Massimo Bellanda; Christian Borgo; Maria Ruzzene; Giacomo Spuri; Ambra Campofelice; Laura Veneziano; Marcella Bonchio; Mauro Carraro; Roberto Battistutta
Journal:  Front Mol Biosci       Date:  2022-06-02

2.  ATR activity controls stem cell quiescence via the cyclin F-SCF complex.

Authors:  Jayesh S Salvi; Jengmin Kang; Soochi Kim; Alex J Colville; Antoine de Morrée; Tine Borum Billeskov; Mikkel Christian Larsen; Abhijnya Kanugovi; Cindy T J van Velthoven; Karlene A Cimprich; Thomas A Rando
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-27       Impact factor: 12.779

3.  Development of small cyclic peptides targeting the CK2α/β interface.

Authors:  Eleanor L Atkinson; Jessica Iegre; Claudio D'Amore; Paul Brear; Mauro Salvi; Marko Hyvönen; David R Spring
Journal:  Chem Commun (Camb)       Date:  2022-04-12       Impact factor: 6.222

4.  Phosphorylation of FAM134C by CK2 controls starvation-induced ER-phagy.

Authors:  Giorgia Di Lorenzo; Francescopaolo Iavarone; Marianna Maddaluno; Ana Belén Plata-Gómez; Simone Aureli; Camila Paz Quezada Meza; Laura Cinque; Alessandro Palma; Alessio Reggio; Carmine Cirillo; Francesca Sacco; Alexandra Stolz; Gennaro Napolitano; Oriano Marin; Lorenzo A Pinna; Maria Ruzzene; Vittorio Limongelli; Alejo Efeyan; Paolo Grumati; Carmine Settembre
Journal:  Sci Adv       Date:  2022-08-31       Impact factor: 14.957

Review 5.  Protein kinase CK2 - diverse roles in cancer cell biology and therapeutic promise.

Authors:  Janeen H Trembley; Betsy T Kren; Muhammad Afzal; George A Scaria; Mark A Klein; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2022-09-17       Impact factor: 3.842

6.  KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR.

Authors:  Claudio D'Amore; Christian Borgo; Valentina Bosello Travain; Mauro Salvi
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

7.  Copper Modulates the Catalytic Activity of Protein Kinase CK2.

Authors:  John E Chojnowski; Rongrong Li; Tiffany Tsang; Fatimah H Alfaran; Alexej Dick; Simon Cocklin; Donita C Brady; Todd I Strochlic
Journal:  Front Mol Biosci       Date:  2022-06-09

8.  CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(-) HNSCC Cell Lines.

Authors:  Janeen H Trembley; Bin Li; Betsy T Kren; Amy A Gravely; Emiro Caicedo-Granados; Mark A Klein; Khalil Ahmed
Journal:  Biomedicines       Date:  2021-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.